Clinical Trials Arena November 2, 2023
The Sylvee device can diagnose chronic obstructive pulmonary disease with 90% accuracy.
US-based start-up Samay announced results for its artificial intelligence (AI) assisted wearable device, Sylvee, in patients with chronic obstructive pulmonary disease (COPD).
Sylvee continuously measures multiple respiratory functions such as air trapping, and pairs with the Sylvee mobile app and a research portal to display results. The device combines lung physiology, internet of things (IoT) sensors, signal processing, and AI/machine learning (ML).
“Our platform continuously captures pulmonary function data, including early COPD diagnostic biomarkers and predictors of exacerbations,” said Samay founder and CEO Maria Artunduaga.
The wearable device market has been steadily increasing since the sudden surge during the Covid-19 pandemic. The market is forecasted to be worth...
Today's Sponsors
Today's Sponsor